Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8605051rdf:typepubmed:Citationlld:pubmed
pubmed-article:8605051lifeskim:mentionsumls-concept:C0019682lld:lifeskim
pubmed-article:8605051lifeskim:mentionsumls-concept:C0019699lld:lifeskim
pubmed-article:8605051lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:8605051lifeskim:mentionsumls-concept:C0239307lld:lifeskim
pubmed-article:8605051lifeskim:mentionsumls-concept:C1883562lld:lifeskim
pubmed-article:8605051lifeskim:mentionsumls-concept:C0001857lld:lifeskim
pubmed-article:8605051lifeskim:mentionsumls-concept:C0209738lld:lifeskim
pubmed-article:8605051lifeskim:mentionsumls-concept:C0231221lld:lifeskim
pubmed-article:8605051lifeskim:mentionsumls-concept:C0547040lld:lifeskim
pubmed-article:8605051lifeskim:mentionsumls-concept:C0162492lld:lifeskim
pubmed-article:8605051lifeskim:mentionsumls-concept:C0205390lld:lifeskim
pubmed-article:8605051lifeskim:mentionsumls-concept:C0301630lld:lifeskim
pubmed-article:8605051lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:8605051pubmed:issue12lld:pubmed
pubmed-article:8605051pubmed:dateCreated1996-5-21lld:pubmed
pubmed-article:8605051pubmed:abstractTextTo evaluate the efficacy of 3TC (lamivudine), a synthetic nucleoside analogue that inhibits HIV reverse transcriptase in vitro, as treatment for HIV-positive, asymptomatic or mild AIDS-related complex patients.lld:pubmed
pubmed-article:8605051pubmed:languageenglld:pubmed
pubmed-article:8605051pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8605051pubmed:citationSubsetIMlld:pubmed
pubmed-article:8605051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8605051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8605051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8605051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8605051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8605051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8605051pubmed:statusMEDLINElld:pubmed
pubmed-article:8605051pubmed:monthDeclld:pubmed
pubmed-article:8605051pubmed:issn0269-9370lld:pubmed
pubmed-article:8605051pubmed:authorpubmed-author:HillAAlld:pubmed
pubmed-article:8605051pubmed:authorpubmed-author:WeberJJlld:pubmed
pubmed-article:8605051pubmed:authorpubmed-author:BoucherC ACAlld:pubmed
pubmed-article:8605051pubmed:authorpubmed-author:LovedayCClld:pubmed
pubmed-article:8605051pubmed:authorpubmed-author:IngrandDDlld:pubmed
pubmed-article:8605051pubmed:authorpubmed-author:RobertCClld:pubmed
pubmed-article:8605051pubmed:authorpubmed-author:CammackNNlld:pubmed
pubmed-article:8605051pubmed:issnTypePrintlld:pubmed
pubmed-article:8605051pubmed:volume9lld:pubmed
pubmed-article:8605051pubmed:ownerNLMlld:pubmed
pubmed-article:8605051pubmed:authorsCompleteYlld:pubmed
pubmed-article:8605051pubmed:pagination1323-9lld:pubmed
pubmed-article:8605051pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8605051pubmed:meshHeadingpubmed-meshheading:8605051-...lld:pubmed
pubmed-article:8605051pubmed:meshHeadingpubmed-meshheading:8605051-...lld:pubmed
pubmed-article:8605051pubmed:meshHeadingpubmed-meshheading:8605051-...lld:pubmed
pubmed-article:8605051pubmed:meshHeadingpubmed-meshheading:8605051-...lld:pubmed
pubmed-article:8605051pubmed:meshHeadingpubmed-meshheading:8605051-...lld:pubmed
pubmed-article:8605051pubmed:meshHeadingpubmed-meshheading:8605051-...lld:pubmed
pubmed-article:8605051pubmed:meshHeadingpubmed-meshheading:8605051-...lld:pubmed
pubmed-article:8605051pubmed:meshHeadingpubmed-meshheading:8605051-...lld:pubmed
pubmed-article:8605051pubmed:meshHeadingpubmed-meshheading:8605051-...lld:pubmed
pubmed-article:8605051pubmed:meshHeadingpubmed-meshheading:8605051-...lld:pubmed
pubmed-article:8605051pubmed:meshHeadingpubmed-meshheading:8605051-...lld:pubmed
pubmed-article:8605051pubmed:meshHeadingpubmed-meshheading:8605051-...lld:pubmed
pubmed-article:8605051pubmed:meshHeadingpubmed-meshheading:8605051-...lld:pubmed
pubmed-article:8605051pubmed:meshHeadingpubmed-meshheading:8605051-...lld:pubmed
pubmed-article:8605051pubmed:meshHeadingpubmed-meshheading:8605051-...lld:pubmed
pubmed-article:8605051pubmed:meshHeadingpubmed-meshheading:8605051-...lld:pubmed
pubmed-article:8605051pubmed:meshHeadingpubmed-meshheading:8605051-...lld:pubmed
pubmed-article:8605051pubmed:year1995lld:pubmed
pubmed-article:8605051pubmed:articleTitlePhase I/II study of 3TC (lamivudine) in HIV-positive, asymptomatic or mild AIDS-related complex patients: sustained reduction in viral markers. The Lamivudine European HIV Working Group.lld:pubmed
pubmed-article:8605051pubmed:affiliationDepartment of Medical Virology, Pitié-Salpétrière Hospital, Paris, France.lld:pubmed
pubmed-article:8605051pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8605051pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:8605051pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:8605051pubmed:publicationTypeMulticenter Studylld:pubmed
pubmed-article:8605051pubmed:publicationTypeClinical Trial, Phase IIlld:pubmed
pubmed-article:8605051pubmed:publicationTypeClinical Trial, Phase Illd:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8605051lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8605051lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8605051lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8605051lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8605051lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8605051lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8605051lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8605051lld:pubmed